E-Prescribing and Opioid Use
E-Prescribing on Opioid-Related Experiences and Outcomes: A Rapid Scoping Review
Project Status:Complete
Knowledge User(s)
Canada Health Infoway
Project Trainee(s)
Stephanie R Cimino, Lauren Cadel, Shanzeh Chaudry
Funding Source(s)
- Canada Health Infoway
Project Objectives
To 1) examine how e-prescribing has been used clinically for opioids; 2) examine the effects of e-prescribing on clinical outcomes, the patient/clinician experience, service delivery, and policy related to opioids; and 3) identify current gaps in the literature to inform future studies and/or recommendations for e-prescribing and opioids.
Research Approach
Rapid Scoping Review
Project Lead(s)
Sara Guilcher
Sara Guilcher is an Associate Professor at the Leslie Dan Faculty of Pharmacy, University of Toronto. Sara and the Optimizing Health and Healthcare Experiences (OPTI-HEx) lab lead science that aims to optimize overall health care delivery, experiences, outcomes and well-being of individuals. Sara’s main areas of research include integration of care, multi-morbidity, self-management, person-centered care, patient safety and hospital harm. Understanding what matters to people with lived experience, care partners, providers and decision makers is critical to co-creating solutions to complex health system issues.
Sara Guilcher
Leslie Dan Faculty of Pharmacy, University of Toronto
Sara Guilcher is an Associate Professor at the Leslie Dan...
Impact Statement
“Infoway is committed to ensuring that digital health initiatives in Canada are built upon the best possible evidence. As PrescribeIT, Canada’s national electronic prescribing service, achieves momentum, there are opportunities to ensure this service and the data it transmits provide the most value to Canadians. This literature will help Infoway and its partners to understand the current and future potential impacts of e-prescribing on opioids and controlled substances. It can inform our actions as we expand and optimize the service, and the complementary initiatives of governments seeking to reduce the negative impacts of opioids.”
– Simon Hagens, Canada Health Infoway